InvestorsHub Logo

marzan

02/28/15 10:57 AM

#43028 RE: BobWayne #43025

Correct. Amarin should at least explain this to the shareholders in this coming CC on have they ever asked FDA how it justifies its rational for urging Amarin to complete R-it which could take up to 2018 and at the same time willing to accept generic filers now? What non sense is this??